Publications (108) MANUEL LIZASOAÍN HERNÁNDEZ publications

2024

  1. Enhancing screening adherence for strongyloides infection in latinx inpatients with COVID-19: a local protocol implementation study

    Pathogens and Global Health, Vol. 118, Núm. 3, pp. 232-240

  2. Spatial Relationship between a Regional Outbreak and a Higher-than-Expected Incidence of Leishmaniasis in Urban Southern Madrid, Spain

    The American journal of tropical medicine and hygiene, Vol. 111, Núm. 4, pp. 814-818

2023

  1. Bacteremia in Patients with Solid Organ Cancer: Insights into Epidemiology and Antibiotic Consumption

    Cancers, Vol. 15, Núm. 23

  2. Cytomegalovirus reactivation in patients with immune-mediated gastritis

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 5, pp. 298-300

  3. Disparities between Latinx migrants and Spanish natives in COVID-19 outcome in Madrid

    Pathogens and Global Health, Vol. 117, Núm. 6, pp. 590-595

  4. Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early-stage symptomatic COVID-19: A real-life experience

    Journal of Medical Virology, Vol. 95, Núm. 9

  5. Prevalence of Chagas disease in Latin American pregnant women in Madrid, Spain: A multicentre cross-sectional study from 2011 to 2016

    Tropical Medicine and International Health, Vol. 28, Núm. 12, pp. 912-922

  6. Production of OXA-48 carbapenemase acts as an independent risk factor for poor outcome in Klebsiella pneumoniae infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 12, pp. 1485-1497

2022

  1. A predictive score at admission for respiratory failure among hospitalized patients with confirmed 2019 Coronavirus Disease: a simple tool for a complex problem

    Internal and Emergency Medicine, Vol. 17, Núm. 2, pp. 515-524

  2. Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

    International Journal of Infectious Diseases, Vol. 117, pp. 56-64

  3. Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa: a tool for guiding empirical antibiotic treatment

    Journal of Global Antimicrobial Resistance, Vol. 29, pp. 215-221

  4. Effectiveness of ceftazidime-avibactam for the treatment of infections due to Pseudomonas aeruginosa

    International Journal of Antimicrobial Agents, Vol. 59, Núm. 2

  5. Higher mortality of hospitalized haematologic patients with COVID-19 compared to non-haematologic is driven by thrombotic complications and development of ARDS: An age-matched cohorts study

    Clinical Infection in Practice, Vol. 13

  6. Infecciones en el paciente inmunodeprimido. Neutropenia febril

    Manual de diagnóstico y terapéutica médica (Hospital Universitario 12 de Octubre), pp. 1162-1178

  7. Prognostic factors of OXA-48 carbapenemase-producing Klebsiella pneumoniae infection in a tertiary-care Spanish hospital: A retrospective single-center cohort study

    International Journal of Infectious Diseases, Vol. 119, pp. 59-68

  8. Risk Factors and Outcomes for Multidrug Resistant Pseudomonas aeruginosa Infection in Immunocompromised Patients

    Antibiotics, Vol. 11, Núm. 11

  9. Time of incubation of agar-plate culture for the diagnosis of Strongyloides stercoralis infection

    Acta Tropica, Vol. 226

2021

  1. Eradication of staphylococcus aureus post-sternotomy mediastinitis following the implementation of universal preoperative nasal decontamination with mupirocin: An interrupted time-series analysis

    Clinical Infectious Diseases, Vol. 73, Núm. 9, pp. 1685-1692

  2. Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: A single-center cohort study

    Journal of Medical Virology, Vol. 93, Núm. 2, pp. 831-842

2020

  1. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies

    European Journal of Haematology, Vol. 105, Núm. 5, pp. 597-607